AnaptysBio
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
10770 Wateridge Cir Ste 210, San Diego, ...Phone Number
(858) 362-6295Website
www.anaptysbio.comRevenue
$232.4 MillionStock Symbol
ANABIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
3
1
1
About AnaptysBio
AnaptysBio, founded in 2005 and headquartered in California, is a clinical-stage biotechnology company focused on developing novel antibody therapeutics. The company specializes in creating treatments for inflammatory diseases and immuno-oncology indications. AnaptysBio's pharmaceutical research and development efforts are centered on innovative antibody-based solutions that address significant medical needs in these therapeutic areas.Explore more
AnaptysBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AnaptysBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on AnaptysBio recently announced quarterly report
AnaptysBio, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at AnaptysBio
Check out if AnaptysBio is spiking on competitors!
Funding: Get notified immidiatlly once AnaptysBio has new funding data
Check if AnaptysBio has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when AnaptysBio launches new products
Click to see if AnaptysBio had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to AnaptysBio
Compare insights from companies similar to AnaptysBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$97.4M
201-500
Public
$237.2M
1997
CE
Celia EckertSenior Vice President, General Counsel & Corporate Secretary
Company Profile Activity
Activity Insights
AnaptysBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
AnaptysBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about AnaptysBio.
AnaptysBio financials insights
Gather financial insights about AnaptysBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2006
Series A
$2M
2007
Series B
$33.9M
2011
Series C
$8M
2013
Debt
$2M
2017
Stock Offering
$75M
2026
Stock/Share Issuance
$145M
AnaptysBio Tech Stack
A closer look at the technologies used by AnaptysBio
See more technologies
Most Recent Scoops
Project
, according to a mid-level source in medical, is in the midst of initiatives related to privacy. The organization is maintaining patient privacy by redacting all patient information from documents captured during clinical trials.
Security, Privacy, Regulations
Project
, according to a mid-level source in medical, is in the midst of initiatives related to clinical software. The organization is currently evaluating CLIN1 Scheduling and NextGen Healthcare. The organization is utilizing software to document interactions with sites and maintain compliance with 21 CFR Part 11 regulations.
Clinical Systems, Compliance, Software, Healthcare Technology, Regulations
Project
, according to a mid-level source in medical, is in the midst of initiatives related to remote patient monitoring (RPM). The organization is streamlining clinical research associate (CRA) workflows by enabling remote monitoring visits for data collection and assessment.
Search, Workforce Management, Authentication, Patient Experience, Telemedicine
Open Position
New Hire
Executive Move
Executive Moves, New Hire
AnaptysBio News & Media
Spin-off dividend tax info posted by AnaptysBio (NASDAQ: ANAB) - Stock Titan
AnaptysBio files IRS Form 8937 and posts details on how the First Tracks Biotherapeutics spin-off dividend is taxed and how shareholders calculate their adjusted tax basis.Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update
SAN DIEGO, May 12, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today reported financial results for the first quarter ended March 31, 2026, and provided a business update.Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors
SAN DIEGO, May 11, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced the appointment of Christopher Murphy as Chief Financial Officer and Owen Hughes as a member of its Board of Directors.Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with GSK and imsidolimab with Vanda, today announced that Daniel Faga, president and chief executive officer of Anaptys, is scheduled to participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 1:30pm ET.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AnaptysBio
Sign Up For FreeTo access detailed company insights
AnaptysBio, founded in 2005 and headquartered in California, is a clinical-stage biotechnology company focused on developing novel antibody therapeutics. The company specializes in creating treatments for inflammatory diseases and immuno-oncology indications. AnaptysBio's pharmaceutical research and development efforts are centered on innovative an... Read More
